The NIAID head said the timing of the end of the pandemic is really up to the public.

Research shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.

Authors of a new study say their findings suggest bariatric surgery should be considered first-line treatment for the management of obesity in patients with type 2 diabetes.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

More than two-thirds of a large group of patients not hospitalized for COVID-19 made at least 1 outpatient visit and left with a new diagnosis within 6 months of their first diagnosis.

The large survey found that 9 out of 10 patients believe their pain levels and quality of life have worsened under the CDC's 2016 opioid prescribing guideline.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Weight loss for patients with NAFLD is the key to improvement of histopathologic features. Find out what else you know about treatment of NAFLD/NASH with 8 guidance-based questions.

New findings suggest that patients with asthma and type 2 diabetes who use GLP-1 RAs for diabetes treatment intensification have fewer asthma exacerbations compared to other diabetes drugs.

US confirmed cases of COVID-19 have surpassed 32 million. Plus more data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

For frontline clinicians who care daily for patients with obesity and type 2 diabetes, a weight-centric approach to T2D, including antiobesity drugs, could help improve outcomes.

The findings suggest that the mouth and its saliva play an important, and perhaps underappreciated, role in SARS-CoV-2 infection and transmission.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Among more than 2 million Americans admitted to the hospital for cannabis use, those with a cardiac arrhythmia were more than 4 times more likely to die while hospitalized than those without.

Long time cardiometabolic investigator Harold Bays, MD, talks about obesity, new drugs to treat the disease, and how the words "be inefficient" could change thinking about treatment.

The April 21st updates include guidance on use of colchicine, when to use combination anti-SARS-CoV-2 monoclonal antibodies, COVID-19 reinfection, and "long COVID."

Primary care physicians face unique challenges when managing patients with obesity, but one obesity specialist aims to show clinicians how to meet them, even if it's in small ways.

Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.

Sex disparities in cardiovascular care in the VA system included less therapy with antiplatelet agents and any intensity statin for women with premature ASCVD than men.

Citing a study of "The Biggest Loser" participants, obesity expert Dr Silvana Pannain explains why "Eat less, exercise more," often backfires as a sole intervention for persons with obesity.